Quarter 2026/Q2
| Line item | 2025 ANNUAL | 2024 ANNUAL | 2023 ANNUAL | 2022 ANNUAL | 2021 ANNUAL |
|---|---|---|---|---|---|
| -Change In Other Working Capital | -$1.35M | -$3.90M | -$8.36M | $18.03M | $14.17M |
| -Change in Payables and Accrued Expense | $30.88M | $38.19M | -$27.32M | -$31.74M | $135.78M |
| -Change in Prepaid Assets | -$24.96M | $2.99M | -$5.50M | -$30.42M | -$30.26M |
| -Change in Inventory | -$1.48M | -$2.33M | -$3.77M | -$22.71M | -$5.72M |
| -Change in Receivables | -$18.40M | -$50.50M | $16.13M | -$71.17M | -$31.93M |
| -Change in Other Current Assets | -$21.40M | -$77.24M | -$39.81M | -$23.38M | $483,000.00 |
| Change in Working Capital | -$36.71M | -$92.80M | -$68.63M | -$161.39M | $82.51M |
| Other Non-Cash Items | $13.62M | $5.84M | $33.30M | $8.43M | $4.82M |
| Deferred Tax | -$20.38M | -$56.48M | -$138.12M | $20.57M | $9.87M |
| Depreciation & Depletion & Amortization | $152.13M | $192.23M | $177.53M | $147.16M | $112.78M |
| Gain/Loss from Continuing Operations | -$43.53M | $42.32M | $8.56M | -$18.23M | $54.91M |
| Net Income from Continuing Operations | $140.16M | -$297.45M | -$798.93M | $43.17M | $9.54M |
| Net cash flow from continuing operations | $330.54M | $243.95M | $228.57M | $197.18M | $283.83M |
| Financing Cash Flow | -$564.97M | -$303.93M | $170.29M | $343.37M | $885.54M |
| Net cash flow from investing | $232.73M | $50.08M | -$451.41M | -$840.28M | -$814.94M |
| Net Cash Flow from Continuing Investing Activities | $232.73M | $50.08M | -$451.41M | -$840.28M | -$814.94M |
| Beginning Cash Balance | $181.10M | $195.11M | $247.17M | $562.79M | $207.81M |
| Net Change in Cash | -$1.70M | -$9.91M | -$52.55M | -$299.74M | $354.43M |
| Ending Cash Balance | $185.05M | $181.10M | $195.11M | $260.77M | $562.79M |
| Net Other Financing Charges | -$14.88M | -$50.26M | -$326,000.00 | $5.31M | -$41.49M |
| Proceeds from Stock Option Exercised | $0.00 | $0.00 | $6.12M | $340,000.00 | $505,000.00 |
| Net Common Stock Issuance | $0.00 | $0.00 | -$49.96M | $0.00 | $717.69M |
| Net Issuance Payments Of Debt | -$550.09M | -$253.68M | $214.46M | $337.72M | $208.84M |
| Net Cash Flow from Continuing Financing Activities | -$564.97M | -$303.93M | $170.29M | $343.37M | $885.54M |
| Free Cash Flow | $107.77M | -$44.68M | -$367.91M | -$239.03M | $123.07M |
| Net Other Investing Changes | $113.00M | – | – | – | – |
| Net Business Purchase and Sale | $269.40M | $287.34M | -$49.59M | -$737.87M | -$798.31M |
| Net PPE Purchase and Sale | $73.10M | $51.37M | $194.66M | $333.80M | $144.13M |
| Capital Expenditure | -$222.77M | -$288.64M | -$596.48M | -$436.21M | -$160.76M |
| Effect of Exchange Rate Changes | $5.65M | -$4.10M | $484,000.00 | -$2.28M | $558,000.00 |
| Operating Cash Flow | $330.54M | $243.95M | $228.57M | $197.18M | $283.83M |
No comments yet — be the first to weigh in on DRVN.